Skip to main content
Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Resistant Dermatomyositis Improves Quickly, Significantly With Combination Drug

Resistant Dermatomyositis Improves Quickly, Significantly With Combination Drug
ShareXFacebook

(MedPage Today) -- DENVER -- Treatment-resistant dermatomyositis improved significantly with the investigational TYK2/JAK1 inhibitor brepocitinib, according to a randomized trial. The higher of two doses of brepocitinib improved the total dermatomyositis...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement